4 / 6
Clin Cardiol J Volume 1 | Issue 1
Page 10
Notes:
December 04-05, 2017 Dallas, USA
International Conference on
Heart Congress, Vascular Biology and Surgeon’s Meeting
Li Zhang
The University of Texas at Dallas, USA
Heme and vascular disrupting agent in non-small cell lung cancer
L
ung cancer is the leading cause of cancer-related death in the US and the world, and non-small cell lung
cancer represents 85% of lung cancer cases. There are many challenges associated with studying and treating
lung cancer, and there is a diverse set of metabolic factors influencing the tumorigenesis and metastasis of lung
cancer. Recent studies have shown that lung cancer cells rely heavily on mitochondrial respiration and that
inhibiting mitochondrial function may be an effective method to combat lung cancer. Further, more research has
noted increased levels of heme flux and function as critical to intensified oxygen consumption and accompanying
amplified pathogenesis and progression of lung cancer. The upregulation of mitochondrial DNA and biogenesis
genes are also correlated with lung cancer. Interestingly, we found that the vascular disrupting agent combretastatin
A-4 phosphate (CA4P) substantially enhanced the levels of enzymes involved in heme biosynthesis, uptake and
degradation, and oxygen-utilizing hemoproteins. Furthermore, detection of markers of mitochondrial function
suggests that CA4P did not diminish mitochondrial function in viable tumor cells. These results suggest that
elevated levels of heme flux and function contribute to tumor regrowth and treatment resistance post-VDA
administration. Novel strategies to inhibit vasculature functions and suppress lung tumors will be discussed.
Biography
Li Zhang has completed her PhD from UCLA and Postdoctoral studies from MIT department of Biology. She is the Cecil H. and Ida Green Distinguished Chair in Sys-
tems Biology Science at the University of Texas at Dallas. Her laboratory has worked on studying heme signaling and function for more than 20 years. She has published
many original research articles and a book entitled
Heme Biology: The Secret Life of Heme in Regulating Diverse Biological Processes
on this subject. Her laboratory has
also made important contributions in understanding the roles of molecular chaperones in cellular signaling, molecular mechanisms of oxygen signaling, and the actions
of neurotoxicants. Recently, her lab focuses on investigating heme function in lung cancer. She and her colleagues have provided a unifying view of cancer bioenergetics
in a review article entitled a holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of
diverse tumors, published in the journal
Clinical and Translational Medicine
.
li.zhang@utdallas.edu